Is Anticoagulation Discontinuation Achievable with Citrate Dialysate during HDF Sessions?

Table 1

Baseline demographic and clinical characteristics.

Numbers of patients
28
Age (years)
71.3 (±15.4)
Men/women
20 (71.4%)/8 (28.6%)
Time on dialysis (years)
3.2 (±3.2)
Causal nephropathy
12 vascular and/or diabetic nephropathy
5 interstitial or obstructive nephropathy
4 glomerular disease
3 undetermined
2 anticalcineurin nephropathy
2 polycystic kidney disease
Nadroparine per session (UI/kg)
52.4 UI/kg (±18.6)
Erythropoietin per session (UI/kg)
137 UI/kg (±144)
Vitamin K antagonists (VKA)/antiplatelet
6 no treatment
11 aspirin alone
2 clopidogrel alone
3 aspirin and clopidogrel
4 VKA
2 VKA and antiplatelet
CRP (mg/L)
6.9 (±6.5)
Hemoglobin (g/dL)
11.6 (±1.0)